Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
Göran Jönsson(Lund University), Åke Borg, Haukur Gunnarsson(Reykjavík University), Markus Ringnér(Lund University), Carina Strand(Lund University), Päivi Heikkilä(University of Helsinki), Oskar T. Johannsson(Lapland Central Hospital), Johan Vallon‐Christersson(Lund University), Kristiina Aittomäki(Helsinki University Hospital), Aðalgeir Arason(University of Iceland), Johan Staaf(Lund University), Bjarni A. Agnarsson(Reykjavík University), Heli Nevanlinna(University of Helsinki), Carl Blomqvist(University of Helsinki), Outi Kilpivaara, Rósa B. Barkardóttir(University of Iceland), Rainer Fagerholm(358 (Finland)), Lena Luts(Lund University), Per Malmström, Niklas Loman(Lund University), Håkan Olsson(Nokia (Finland)), Karolina Holm(Lund University), Cecilia Hegardt(Lund University)
Cited by 194
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k